News ZTlido Labeling Updated With Clinical Data on Water Exposure By Brian Park, PharmD Publish Date April 12, 2021
News Ankle Sprain Treatment in the ED: Pain Med Trends Examined By Cassandra Pardini, PharmD Publish Date April 2, 2021
Drugs in the Pipeline Atogepant Under Review for Episodic Migraine Prevention By Diana Ernst, RPh Publish Date March 30, 2021
Drugs in the Pipeline FDA Panel Votes on Tanezumab for Osteoarthritis Pain By Diana Ernst, RPh Publish Date March 29, 2021
News Case Report: Pain Med Dose Linked to Patient’s Sleepwalking By Cassandra Pardini, PharmD Publish Date March 23, 2021
Safety Alerts and Recalls FDA Cracks Down on Companies Selling Unapproved CBD Products By Diana Ernst, RPh Publish Date March 23, 2021
Safety Alerts and Recalls Possible Sterility Breach Prompts Recall of Phenylephrine Hydrochloride Injection By Brian Park, PharmD Publish Date March 12, 2021
News NSAID May Increase AKI Risk in Hospitalized Children By Natasha Persaud Publish Date March 9, 2021
News NeuroSphere Virtual Clinic Allows for Remote Neuromodulation Therapy Management By Brian Park, PharmD Publish Date March 9, 2021
News FDA Clears Wearable Brain Neuromodulation Device for Acute Migraine By Brian Park, PharmD Publish Date March 3, 2021
News Vazalore, a Liquid-Filled Capsule Formulation of Aspirin, Gets FDA Approval By Brian Park, PharmD Publish Date March 2, 2021
News FDA Approves Acetaminophen Injection in Multiple Doses By Brian Park, PharmD Publish Date February 26, 2021
News FDA Issues Warning Letter for Misleading Promotion of Opioid Analgesic Dsuvia By Brian Park, PharmD Publish Date February 16, 2021
News FDA Clears Vagus Nerve Stimulation Device for Adolescent Migraine By Brian Park, PharmD Publish Date February 16, 2021
Features Expert Perspective: The Opioid Crisis and COVID-19 By Benjamin Williams Publish Date February 16, 2021